.svg)
.svg)
Projected pharmacy savings only become financial results when employees actually enroll, migrate prescriptions, and remain engaged over time.
The “last and longest mile,” as we call it internally is adoption, and brokers play a central role in determining whether pharmacy strategies successfully cross it. At Aphora Health, we invest heavily in supporting brokers and employer partners by pairing our Pharmacy Savings Architecture with a designed member experience and transparent reporting that converts projected savings into measurable results.
In Part I, we established that projected savings do not equal realized impact. Modeled reductions in unit cost create opportunity, but adoption determines whether that opportunity becomes financial performance.
In Part II, we examined this dynamic from the employer’s perspective. Employers ultimately experience the financial outcome. Adoption velocity, prescription migration, and sustained engagement determine whether projections translate into realized savings.
Part III looks at the same operational reality from another critical vantage point: the broker and benefits advisor.
Brokers occupy a unique position in pharmacy strategy. They are critical in helping employers evaluate vendors, interpreting financial models, and guiding the decision-making process. Their influence does not end when a program is selected. In many ways, this is where it begins.
The transition from strategy to performance is where many pharmacy initiatives either accelerate or stall.
Employers often review proposals that show compelling modeled savings and make a clear financial case. Specialty cost compression is illustrated, generic utilization improvements are projected, and the pricing architecture appears disciplined.
But the operational path between a signed agreement and realized savings runs directly through employee adoption.
If eligible employees do not enroll, if prescriptions are slow to migrate, or if engagement fades after initial enrollment, claims continue to flow through legacy channels. Higher-cost fulfillment persists. Generic capture lags projections. Over time, the operational results do not reflect what was modeled.
This is one area where broker guidance becomes especially important.
Brokers help employers move beyond evaluating pharmacy strategy purely through financial modeling. They can help frame the operational questions that determine whether a program will actually perform.
How quickly will employees enroll? How frictionless is the prescription migration process? What percentage of eligible employees convert within the first 90 days? What reporting is provided to measure adoption progress and realized savings?
These questions shift the conversation from theoretical savings to operational performance.
For our part, we like to see between 10-15% member enrollment in the first 7 days. This typically points to 50%+ over 30 days of our normal enrollment program. Every 1% matters, whether we are working with a small company or a nationwide employer.
Brokers also play a critical role in setting expectations around communication and rollout strategy. Pharmacy transitions can create hesitation among employees if they appear disruptive or unclear. Structured communication, clear messaging, and ongoing reinforcement help reduce uncertainty and accelerate adoption.
When communication is intentional and coordinated, employees are far more likely to enroll, migrate prescriptions, and remain engaged. This is one reason we invest so heavily in this area.
Measurement is equally important. Employers and advisors should be able to see adoption performance clearly, not only through financial summaries but through operational metrics that show how the program is progressing.
Eligible population, enrollment rate, prescription migration velocity, and member retention all provide visibility into whether the strategy is performing as expected. Without that visibility, adoption challenges may remain hidden until financial outcomes fall short of projections.
High-performing pharmacy strategies tend to share a common structure. They combine disciplined cost architecture, intentional member experience design, and transparent reporting that allows employers and brokers to monitor adoption performance over time.
When these elements work together, modeled savings have a much stronger likelihood of becoming realized financial impact.
At Aphora Health, we work closely with brokers and employer partners to ensure pharmacy strategy performs operationally, not just financially.
Our Pharmacy Savings Architecture focuses on disciplined cost structure across specialty and generic pathways. Alongside that financial design, we implement a structured Member Experience model that supports employee education, simplifies enrollment, and removes friction from prescription migration.
Equally important, we provide transparent reporting that allows employers and advisors to monitor adoption performance and track realized savings against projections.
Adoption is the bridge between modeled savings and financial results. Brokers and benefits advisors are often the architects of that bridge.
If you are evaluating pharmacy strategy and want clearer visibility into how projected savings convert into measurable financial outcomes across your employer portfolio, we welcome the conversation. Feel free to schedule a time that works for you: https://aphorahealth.com/contact-us
